Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
7.27M
-
Shares change
-
+474K
-
Total reported value, excl. options
-
$239M
-
Value change
-
+$15.3M
-
Put/Call ratio
-
1.9
-
Number of buys
-
37
-
Number of sells
-
-55
-
Price
-
$32.82
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q3 2021
122 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q3 2021.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.27M shares
of 22.3M outstanding shares and own 32.65% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.51M shares), VANGUARD GROUP INC (645K shares), THOMPSON SIEGEL & WALMSLEY LLC (451K shares), STATE STREET CORP (411K shares), DIMENSIONAL FUND ADVISORS LP (378K shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (374K shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (334K shares), GOLDMAN SACHS GROUP INC (311K shares), FEDERATED HERMES, INC. (277K shares), and AMERIPRISE FINANCIAL INC (274K shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.